Phibro Animal Health Corporation · NASDAQ:PAHC
Phibro Animal Health — Q2 FY2020 Earnings Presentation
12 slides from Phibro Animal Health's earnings presentation, Feb 4, 2020
Slide 1: Phibro Animal Health Corporation Second Quarter Webcast and Conference Call
Phibro Animal Health Corporation Second Quarter – December 31, 2019 U.S. toll-free +1-866-211-3051 Webcast and Conference Call International toll +1-647-689-6616 February 4, 2020 Conference ID: 9179438
Slide 2: Cautionary Statements
Cautionary Statements Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact included in this report are forward-looking statements. Forward-looking statements d
Slide 3: GAAP and Non-GAAP Financial Information
GAAP and Non-GAAP Financial Information Reported results are presented in accordance with GAAP Adjusted results are GAAP results adjusted to exclude - Acquisition-related items, including intangible amortization, cost of goods sold, accrued compensation costs, transaction costs and accrued interest
Slide 4: Opening Remarks and Financial Review
Opening Remarks and Financial Review Jack Bendheim Chairman, President, Chief Executive Officer Richard Johnson Chief Financial Officer 4 February 4, 2020 Webcast and Conference Call
Slide 5: Highlights Q2 – December 2019
Highlights Q2 – December 2019 Increased sales in the Animal Health business were Consolidated more than offset by lower average selling prices in Mineral Nutrition and decreased volume in For the three months ended Performance Products. The increase in Animal 2019 2018 Change December 31 Health was
Slide 6: Selected Line Items
Selected Line Items Q2 – December 2019 Consolidated Adjusted gross profit - Animal Health volume growth in nutritional For the three months ended December 31 2019 2018 Change specialty products and vaccines were partially (in millions, except per share amounts and percentages) offset by lower volume
Slide 7: Animal Health
Animal Health Q2 – December 2019 MFAs and other - Lower demand in China due to ASF Animal Health - Increased domestic demand For the three months ended - China customer purchases made in advance of 2019 2018 Change December 31 regulatory changes, effective January 1, 2020. (in millions, except perce
Slide 8: Other Segments
Other Segments Q2 – December 2019 For the three months ended 2019 2018 Change December 31 Mineral Nutrition (in millions, except percentages) - Sales decreased due to lower average selling Mineral Nutrition prices and lower volume Net sales $ 55.7 $ 62.3 $ (6.6) (11)% - Adjusted EBITDA decrease driv
Slide 9: Capitalization
Capitalization December 31, 2019 3.6x leverage ratio at December 31, 2019 - $374 million total debt - $105 million Adjusted EBITDA $75 million cash and short-term investments on hand at December 31, 2019 $23 million source of cash before financing for the December 2019 quarter, excluding changes in
Slide 10: Guidance
Guidance Year – June 2020 Phibro Animal Health Corporation Updated Guidance for fiscal year 2020 Change from Previous For the year ending June 30 2020 2019 Change from 2019 Guidance (in millions, except per share amounts and percentages) Net sales - Animal Health segment $ 537 - $ 547 $ 532 $ 5 - $
Slide 11: Q&A Session
Q&A Session 11 February 4, 2020 Webcast and Conference Call
Slide 12: © 2020 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy
© 2020 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy Animals. Healthy Food. Healthy World.; and any other Phibro brand or brands shown herein are trademarks owned by or licensed to Phibro Animal Health Corporation or its affiliates. Any other trademark that
Phibro Animal Health — Q2 FY2020 Earnings Presentation on 6ix